Innovate UK welcomes global firm to Cell & Gene Catapult centre
TCR2 Therapeutics will become the first international organisation to work with the Cell and Gene Therapy Catapult manufacturing centre.
Innovate UK, part of UK Research and Innovation, yesterday welcomed the announcement that immunotherapy company, TCR2 Therapeutics, is to become the first US organisation to work with the Cell and Gene Therapy (CGT) Catapult at its Stevenage manufacturing centre. TCR2 has selected the facility to establish a site for global manufacturing and capability development to advance novel T cell receptor therapies for patients suffering from cancer.
Dr Ian Campbell, Interim Executive Chair, Innovate UK yesterday said:
By choosing to work with the Cell & Gene Therapy Catapult manufacturing centre, TCR2 Therapeutics demonstrates to the world that the UK is a global leader in this sector. Advanced cell and gene therapies show great promise in treating conditions such as cancer. It is vital to support research and development that could result in huge improvements in patient outcomes.
Boosted by investment through the government’s modern Industrial Strategy and the life sciences sector deal, the UK can realise both the commercial and societal benefits from these advances in this vital and thriving sector.
Dr Kath Mackay, Interim Director – Ageing Society, Health & Nutrition, Innovate UK, added:
The decision by TCR2 Therapeutics to establish a presence at the Cell & Gene Therapy Catapult manufacturing centre is a major international vote of confidence in the UK life sciences sector. The Cell and Gene Therapy Catapult manufacturing centre is a world-leading facility, bringing the manufacture of pioneering treatments closer to patients. The decision recognises the level and maturity of government investment into UK manufacturing capability and the associated supply chain.
UK Research and Innovation, through the government’s Industrial Strategy Challenge Fund, backs this crucial component of the modern Industrial Strategy, building the jobs and industries of tomorrow. We have underlined our support by also funding three new Advanced Therapy Treatment Centres to complement the work of the manufacturing centre. Working across the UK, this network will support the roll-out of cell and gene therapies, bringing together expert clinicians, researchers, scientists, developers and private companies to demonstrate the benefits for patients.
The CGT Catapult manufacturing centre in Stevenage, opened in April 2018, is backed by more than £60 million of government investment, including funding from Innovate UK and the Industrial Strategy Challenge Fund (ISCF). TCR2 joins advanced therapy companies Adaptimmune, Autolus, Cell Medica, and Freeline.
Working with the manufacturing centre are the three UK Advanced Therapies Treatment Centres, which were awarded £21 million in through the ISCF Medicines Manufacturing challenge. The centres are collaborative ventures between industry, academic and NHS partners. They comprise the Innovate Manchester Advanced Therapy Centre Hub (iMATCH), the Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC, comprising Birmingham, Wales and Nottingham) and the Northern Alliance Advanced Therapies Treatment Centre (NAATTC, comprising Scotland, Newcastle and Leeds).
Latest News from
Queen’s Awards success for businesses backed by Innovate UK24/04/2019 13:25:00
1 in 5 winners in the 2019 Queen’s Award for Enterprise have received support and funding from Innovate UK.
Evaluating medical innovations: apply for funding17/04/2019 12:25:00
Organisations can apply for a share of £1.5 million to help evaluate medical devices in real-world clinical settings.
Transforming UK aerospace: funding for projects16/04/2019 14:20:00
Projects that could strengthen the UK aerospace industry through new technologies are invited to participate in a regular competition.
Four leading edge demonstrators to jumpstart energy revolution04/04/2019 09:10:00
Managing energy though machine learning and new lithium ion battery storage are among the 4 innovative projects announced yesterday.
£9m awarded to breakthrough digital health technologies29/03/2019 15:25:00
Patients to benefit from AI, machine learning and hand-held devices as newly-funded digital projects by pioneering companies point to future of healthcare
Next step in photonic technologies: apply for funding28/03/2019 09:10:00
Organisations can apply for a share of £2 million to develop advanced photonic technologies in international partnerships.
Monitoring housing for better health: apply for funding26/03/2019 09:15:00
Organisations can apply for a share of £1.25 million to develop new ways to monitor domestic heat and energy.
Creating the 5G network: apply for funding19/03/2019 14:10:00
Businesses can apply for a share of £1 million for international partnerships that will help develop 5G internet connectivity.